Cutaneous complications in diabetes mellitus: pathophysiology, clinical relevance and the role of physical activity in prevention – a literature review
DOI:
https://doi.org/10.12775/QS.2025.45.66480Keywords
diabetes mellitus, skin manifestations, cutaneous complication, physical activityAbstract
Diabetes mellitus is a chronic metabolic disease leading to a number of complications, including skin lesions, which may be the first sign of hyperglycaemia or indicative of advanced disease. In recent years, increasing attention has been paid to the role of physical activity not only in improving glycaemic control, but also in reducing the pathophysiological processes responsible for the cutaneous manifestations of diabetes. The aim of this study was to present the most common cutaneous lesions in patients with diabetes, their mechanisms of formation and to assess the impact of physical activity on their occurrence and course.
References
1. Abate MCM de O, Aroucha PMT, Nóbrega DVM da, et al. Cutaneous manifestations of diabetes mellitus: a narrative review. Einstein Sao Paulo Braz. 2025;23:eRW1193. doi:10.31744/einstein_journal/2025RW1193
2. Kanaley JA, Colberg SR, Corcoran MH, et al. Exercise/Physical Activity in Individuals with Type 2 Diabetes: A Consensus Statement from the American College of Sports Medicine. Med Sci Sports Exerc. 2022;54(2):353-368. doi:10.1249/MSS.0000000000002800
3. Rietz M, Lehr A, Mino E, et al. Physical Activity and Risk of Major Diabetes-Related Complications in Individuals With Diabetes: A Systematic Review and Meta-Analysis of Observational Studies. Diabetes Care. 2022;45(12):3101-3111. doi:10.2337/dc22-0886
4. Venkatasamy VV, Pericherla S, Manthuruthil S, Mishra S, Hanno R. Effect of Physical activity on Insulin Resistance, Inflammation and Oxidative Stress in Diabetes Mellitus. J Clin Diagn Res JCDR. 2013;7(8):1764-1766. doi:10.7860/JCDR/2013/6518.3306
5. Edwards E, Yosipovitch G. Skin Manifestations of Diabetes Mellitus. In: Feingold KR, Ahmed SF, Anawalt B, et al., eds. Endotext. MDText.com, Inc.; 2000. Accessed May 22, 2025. http://www.ncbi.nlm.nih.gov/books/NBK481900/
6. Chatterjee N, Chattopadhyay C, Sengupta N, Das C, Sarma N, Pal SK. An observational study of cutaneous manifestations in diabetes mellitus in a tertiary care Hospital of Eastern India. Indian J Endocrinol Metab. 2014;18(2):217-220. doi:10.4103/2230-8210.129115
7. Dryden M, Baguneid M, Eckmann C, et al. Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2015;21 Suppl 2:S27-32. doi:10.1016/j.cmi.2015.03.024
8. Luo X, Wu J, Jing S, Yan LJ. Hyperglycemic Stress and Carbon Stress in Diabetic Glucotoxicity. Aging Dis. 2016;7(1):90-110. doi:10.14336/AD.2015.0702
9. Yan LJ. Pathogenesis of chronic hyperglycemia: from reductive stress to oxidative stress. J Diabetes Res. 2014;2014:137919. doi:10.1155/2014/137919
10. Wang AJ, Wang A, Hascall V. Detoxification of Hyperglycemia-induced Glucose Toxicity by the Hexosamine Biosynthetic Pathway. Front Biosci Landmark Ed. 2024;29(2):71. doi:10.31083/j.fbl2902071
11. Xiao Y, Qian J, Deng X, et al. Macrophages regulate healing-associated fibroblasts in diabetic wound. Mol Biol Rep. 2024;51(1):203. doi:10.1007/s11033-023-09100-1
12. Icli B, Nabzdyk CS, Lujan-Hernandez J, et al. Regulation of impaired angiogenesis in diabetic dermal wound healing by microRNA-26a. J Mol Cell Cardiol. 2016;91:151-159. doi:10.1016/j.yjmcc.2016.01.007
13. Monnier VM, Bautista O, Kenny D, et al. Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT Skin Collagen Ancillary Study Group. Diabetes Control and Complications Trial. Diabetes. 1999;48(4):870-880. doi:10.2337/diabetes.48.4.870
14. Van Putte L, De Schrijver S, Moortgat P. The effects of advanced glycation end products (AGEs) on dermal wound healing and scar formation: a systematic review. Scars Burns Heal. 2016;2:2059513116676828. doi:10.1177/2059513116676828
15. Bodman MA, Dreyer MA, Varacallo MA. Diabetic Peripheral Neuropathy. In: StatPearls. StatPearls Publishing; 2025. Accessed May 23, 2025. http://www.ncbi.nlm.nih.gov/books/NBK442009/
16. Volmer-Thole M, Lobmann R. Neuropathy and Diabetic Foot Syndrome. Int J Mol Sci. 2016;17(6):917. doi:10.3390/ijms17060917
17. Samjoo IA, Safdar A, Hamadeh MJ, Raha S, Tarnopolsky MA. The effect of endurance exercise on both skeletal muscle and systemic oxidative stress in previously sedentary obese men. Nutr Diabetes. 2013;3(9):e88. doi:10.1038/nutd.2013.30
18. Čížková T, Štěpán M, Daďová K, et al. Exercise Training Reduces Inflammation of Adipose Tissue in the Elderly: Cross-Sectional and Randomized Interventional Trial. J Clin Endocrinol Metab. 2020;105(12):e4510-e4526. doi:10.1210/clinem/dgaa630
19. Bueno M, Calyeca J, Rojas M, Mora AL. Mitochondria dysfunction and metabolic reprogramming as drivers of idiopathic pulmonary fibrosis. Redox Biol. 2020;33:101509. doi:10.1016/j.redox.2020.101509
20. Williams DT, Harding KG, Price PE. The influence of exercise on foot perfusion in diabetes. Diabet Med. 2007;24(10):1105. doi:10.1111/J.1464-5491.2007.02218.X
21. Monnier VM, Sell DR, Gao X, et al. Plasma advanced glycation end products and the subsequent risk of microvascular complications in type 1 diabetes in the DCCT/EDIC. BMJ Open Diabetes Res Care. 2022;10(1):e002667. doi:10.1136/bmjdrc-2021-002667
22. Bahadursingh S, Mungalsingh C, Seemungal T, Teelucksingh S. Acanthosis nigricans in type 2 diabetes: prevalence, correlates and potential as a simple clinical screening tool - a cross-sectional study in the Caribbean. Diabetol Metab Syndr. 2014;6:77. doi:10.1186/1758-5996-6-77
23. González-Saldivar G, Rodríguez-Gutiérrez R, Treviño-Alvarez AM, et al. Acanthosis nigricans in the knuckles: An early, accessible, straightforward, and sensitive clinical tool to predict insulin resistance. Dermatoendocrinol. 2018;10(1):e1471958. doi:10.1080/19381980.2018.1471958
24. Naik PP, Farrukh SN. Clinical Significance of Diabetic Dermatopathy. Diabetes Metab Syndr Obes Targets Ther. 2020;13:4823-4827. doi:10.2147/DMSO.S286887
25. Kota SK, Jammula S, Kota SK, Meher LK, Modi KD. Necrobiosis lipoidica diabeticorum: A case-based review of literature. Indian J Endocrinol Metab. 2012;16(4):614-620. doi:10.4103/2230-8210.98023
26. Cole GW, Headley J, Skowsky R. Scleredema Diabeticorum: A Common and Distinct Cutaneous Manifestation of Diabetes Mellitus. Diabetes Care. 1983;6(2):189-192. doi:10.2337/diacare.6.2.189
27. Suaya JA, Eisenberg DF, Fang C, Miller LG. Skin and soft tissue infections and associated complications among commercially insured patients aged 0-64 years with and without diabetes in the U.S. PloS One. 2013;8(4):e60057. doi:10.1371/journal.pone.0060057
28. Poradzka A, Jasik M, Karnafel W, Fiedor P. Clinical aspects of fungal infections in diabetes. Acta Pol Pharm. 2013;70(4):587-596.
29. Saud B, Bajgain P, Paudel G, et al. Fungal Infection among Diabetic and Nondiabetic Individuals in Nepal. Interdiscip Perspect Infect Dis. 2020;2020:7949868. doi:10.1155/2020/7949868
30. Stefaniak AA, Chlebicka I, Szepietowski JC. Itch in diabetes: a common underestimated problem. Postepy Dermatol Alergol. 2021;38(2):177-183. doi:10.5114/ada.2019.89712
31. David P, Singh S, Ankar R. A Comprehensive Overview of Skin Complications in Diabetes and Their Prevention. Cureus. 2023;15(5):e38961. doi:10.7759/cureus.38961
32. Raja JM, Maturana MA, Kayali S, Khouzam A, Efeovbokhan N. Diabetic foot ulcer: A comprehensive review of pathophysiology and management modalities. World J Clin Cases. 2023;11(8):1684-1693. doi:10.12998/wjcc.v11.i8.1684
33. Persad-Paisley EM, Lee C, Bhatt RA. Understanding diabetic cheiroarthropathy: a focus on clinical presentation. J Surg Case Rep. 2024;2024(3):rjae123. doi:10.1093/jscr/rjae123
34. Dogiparthi SN, Muralidhar K, Seshadri KG, Rangarajan S. Cutaneous manifestations of diabetic peripheral neuropathy. Dermatoendocrinol. 2017;9(1):e1395537. doi:10.1080/19381980.2017.1395537
35. Mader JK, Fornengo R, Hassoun A, et al. Relationship Between Lipohypertrophy, Glycemic Control, and Insulin Dosing: A Systematic Meta-Analysis. Diabetes Technol Ther. 2024;26(5):351. doi:10.1089/dia.2023.0491
36. Kong AS, Williams RL, Smith M, et al. Acanthosis nigricans and diabetes risk factors: prevalence in young persons seen in southwestern US primary care practices. Ann Fam Med. 2007;5(3):202-208. doi:10.1370/afm.678
37. Dadgal KV, Mohod S. A Case Report With Dual Diagnosis of Candidiasis in a Patient With Uncontrolled Diabetes Mellitus. Cureus. 2024;16(7):e65908. doi:10.7759/cureus.65908
38. El-Gilany AH, Fathy H. Risk factors of recurrent furunculosis. Dermatol Online J. 2009;15(1):16.
39. Mandal N, Praveen P, Sen S, Banerjee S, Dey P, Mandal S. Cutaneous manifestations of diabetes mellitus: Correlation with HbA1C level—A cross-sectional observational study from a tertiary care center in Eastern India. Ann Med Sci Res. 2023;2(3):144. doi:10.4103/amsr.amsr_57_22
40. Sugimoto K, Murakami H, Deguchi T, et al. Cutaneous microangiopathy in patients with type 2 diabetes: Impaired vascular endothelial growth factor expression and its correlation with neuropathy, retinopathy and nephropathy. J Diabetes Investig. 2019;10(5):1318-1331. doi:10.1111/jdi.13020
41. Kamel MI, Elhenawy YI, Saudi WM. Relation between cutaneous and extracutaneous complications in pediatric patients with type 1 diabetes. Dermatoendocrinol. 2018;10(1):e1467717. doi:10.1080/19381980.2018.1467717
42. Azizian Z, Behrangi E, Hasheminasabzavareh R, Kazemlo H, Esmaeeli R, Hassani P. Prevalence Study of Dermatologic Manifestations among Diabetic Patients. Adv Prev Med. 2019;2019(1):5293193. doi:10.1155/2019/5293193
43. Boulton AJM, Armstrong DG, Albert SF, et al. Comprehensive foot examination and risk assessment: a report of the task force of the foot care interest group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists. Diabetes Care. 2008;31(8):1679-1685. doi:10.2337/dc08-9021
44. Gupta AK, Shemer A, Economopoulos V, Talukder M. Diabetic Foot and Fungal Infections: Etiology and Management from a Dermatologic Perspective. J Fungi Basel Switz. 2024;10(8):577. doi:10.3390/jof10080577
45. Mader JK, Fornengo R, Hassoun A, et al. Relationship Between Lipohypertrophy, Glycemic Control, and Insulin Dosing: A Systematic Meta-Analysis. Diabetes Technol Ther. 2024;26(5):351-362. doi:10.1089/dia.2023.0491
46. Narbutt J, Bednarski IA, Lesiak A. The effect of an emollient with benfothiamine and Biolin prebiotic on the improvement of epidermal skin function. Postepy Dermatol Alergol. 2016;33(3):224-231. doi:10.5114/ada.2016.60616
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Paulina Sara Kulasza, Weronika Kalinowska, Michał Szczepański, Natalia Dzieszko, Maciej Borowski, Aleksandra Szeliga, Tomasz Karol Ksiazek, Piotr Mikolaj Dembicki, Anna Ewelina Francuziak, Kinga Kozlowska
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 90
Number of citations: 0
